The objective of this study is to evaluate the pharmacokinetics of Luliconazole Cream 1%, as measured by circulating plasma levels of luliconazole, when maximal quantity of Luliconazole Cream 1% is applied to patients 12 years to < 18 years of age with moderate to severe inter-digital tinea pedis or tinea cruris.